Microfluidics

Clinical Translation & Commercialization

Clinical translation and commercialization of microfluidic technologies involve transforming laboratory innovations into reliable, scalable products that address real-world healthcare needs. Success depends on robust validation, regulatory approval, manufacturability, and user-centered design. Key considerations include material compatibility, device durability, cost-efficiency, and seamless integration with clinical workflows. Collaboration among researchers, clinicians, industry partners, and regulatory agencies accelerates product development and market readiness. Scalable manufacturing methods such as injection molding, roll-to-roll processing, and hybrid fabrication enable mass production of microfluidic devices for diagnostics, drug delivery, and monitoring solutions. Commercialization efforts increasingly emphasize digital integration, cloud-based data systems, and interoperability. As global demand for portable diagnostics, personalized therapies, and automated laboratory systems grows, microfluidic technologies continue to advance toward widespread clinical adoption, shaping the future of healthcare innovation.